BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22828265)

  • 1. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
    Nakada T; Matsuzawa Y
    Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
    Arikawa J; Okabe S; Kaneko T
    J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
    Wong GN; Shen S; Nixon R
    Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
    [No Abstract]   [Full Text] [Related]  

  • 5. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
    Proske S; Uter W; Schnuch A; Hartschuh W
    Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis from bufexamac cream.
    Corazza M; Roveggio C; Virgili A
    Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
    Gniazdowska B; Ruëff F; Przybilla B
    Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
    Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
    Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
    Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
    Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe contact dermatitis caused by Parfenac cream].
    Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
    Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact sensitivity to budesonide in a child.
    Auricchio L; Nino M; Suppa F
    Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe contact dermatitis caused by bufexamac with large flap desquamation].
    Landrieux C; Estève E; Serpier H; Kalis B
    Ann Dermatol Venereol; 1996; 123(3):198-9. PubMed ID: 8761786
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
    Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
    Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis due to indomethacin and diclofenac.
    Gómez A; Florido JF; Quiralte J; Martín AE; Sáenz de San Pedro B
    Contact Dermatitis; 2000 Jul; 43(1):59. PubMed ID: 10902602
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact dermatitis caused by bufexamac sparing the eruption of herpes zoster.
    Fukuda H; Sato Y; Usami N; Yokouchi Y; Mukai H
    J Dermatol; 2012 Apr; 39(4):405-7. PubMed ID: 21950459
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical NSAID allergic contact dermatitis. Italian experience.
    Pigatto PD; Mozzanica N; Bigardi AS; Legori A; Valsecchi R; Cusano F; Tosti A; Guarrera M; Balato N; Sertoli A
    Contact Dermatitis; 1993 Jul; 29(1):39-41. PubMed ID: 8365153
    [No Abstract]   [Full Text] [Related]  

  • 19. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
    Kurumaji Y
    Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact sensitivity to 5 different ingredients of a topical medicament (Imacort cream).
    Brand CU; Ballmer-Weber BK
    Contact Dermatitis; 1995 Aug; 33(2):137. PubMed ID: 8549141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.